The Role of Caffeine in Noninvasive Respiratory Support Versus Aminophylline in Prematurity Apnea
DOI:
https://doi.org/10.56981/Keywords:
Caffeine, Noninvasive Respiratory Support, Aminophylline, ApneaAbstract
Caffeine plays a key role in noninvasive respiratory support, easing the transition from invasive to noninvasive support, shortening the length of positive airway pressure support, and lowering BPD risk. Caffeine and aminophylline are effective in decreasing apnoea and facilitating and ventilator weaning in extremely preterm newborns. This study aims to investigate the clinical significance of caffeine and aminophylline in treating premature infants with apnea under varying conditions of oxygen (O2) delivery.
The current study included 38 preterm babies with apnea who underwent caffeine or aminophylline treatment at the Al-Mahaweel General Hospital between January and December 2020; the infants were 20 boys and 18 girls, with birth weights ranging from 500 to 1,250 grams.
The study came out to the result that caffeine plays a key role in noninvasive respiratory support, easing the transition from invasive to noninvasive support, shortening the length of positive airway pressure support, and lowering BPD risk. Caffeine and
aminophylline both are effective in decreasing apnoea and facilitating and ventilator weaning in extremely preterm newborns. Caffeine has therapeutic advantages over aminophylline, such as better enteral absorption, a longer half-life that allows for a single daily dose, reduced side effects, and a good long-term cost/benefit ratio, making it the first choice drug for the cure of apnoea in premature neonates.
References
1. Williamson, J. R., Bliss, D. W., & Paydarfar, D. (2013). Forecasting respiratory collapse: theory and practice for averting life-threatening infant apneas. Respiratory physiology & neurobiology, 189(2), 223-231.
2. Eichenwald, E. C. (2016). Apnea of prematurity. Pediatrics, 137(1).
3. Mathew, O. P. (2011). Apnea of prematurity: pathogenesis and management strategies. Journal of Perinatology, 31(5), 302-310.
4. Di Fiore, J. M., Martin, R. J., & Gauda, E. B. (2013). Apnea of prematurity–perfect storm. Respiratory physiology & neurobiology, 189(2), 213-222.
5. Huxtable, A. G., Smith, S. M., Peterson, T. J., Watters, J. J., & Mitchell, G. S. (2015). Intermittent hypoxia-induced spinal inflammation impairs respiratory motor plasticity by a spinal p38 MAP kinase-dependent mechanism. Journal of Neuroscience, 35(17), 6871-6880.
6. Caffeine versus aminophylline in combination with oxygen therapy for apnea of prematurity: A retrospective cohort study cheng-yun zhang1*, dong-jie liu1*, shao-dong hua2*, shan guo3, xiao-yan li1, bing zhang1 and li-hua an1, doi: 10.3892/etm.2020.9175.
7. Treatment options for apnoea of prematurity Sarah U Morton,1 Vincent C Smith2, 1Harvard Neonatal-Perinatal Fellowship Program, Boston Children’s Hospital Boston, Boston, Massachusetts, USA, Published by group.bmj.com.
8. Comparing the efficacy of Aminophylline and Caffeine in treatment of apnea of prematurity; A Randomized Clinical Trial Bita Najafian M.D.1, Faezeh Asadollahi Pharm.D.2, Majid Shohrati Ph.D.3*,www.canonjm.com
9. Moschino, L., Zivanovic, S., Hartley, C., Trevisanuto, D., Baraldi, E., & Roehr, C. C. (2020). Caffeine in preterm infants: where are we in 2020?. ERJ open research, 6(1).
10. Dobson, N. R., & Patel, R. M. (2016). The role of caffeine in noninvasive respiratory support. Clinics in perinatology, 43(4), 773-782.
11. Zonda, G. I., Avasiloaiei, A., Moscalu, M., & Stamatin, M. (2016). comparison of the efficiency of caffeine versus aminophylline for the treatment of apnoea of prematurity. romanian journal of pediatrics, 65(1), 28.
12. Committee on Fetus and Newborn. American Academy of Pediatrics. Apnea, sudden infant death syndrome, and home monitoring. Pediatrics 2003; 111: 914-917.
13. Arora P. Pathogenesis and Management of Apnea of Prematurity: A Brief Overview. J Neonatal Bio 2012; 1:e104.
14. Mueni E., Opiyo N., English M. Caffeine for the management of apnea in preterm infants Int Health 2009; 1(2):190-195.
15. Atkinson E., Fenton A.C. Management of apnoea and bradycardia in neonates Paediatrics and Child Health 2009; 19(12):550-554.5. Zhao J., Gonzalez F., Mu D. Apnea of prematurity: from cause totreatment Eur J Pediatr 2011; 170:1097-1105
16. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A and Tin W; Caffeine for Apnea of Prematurity Trial Group: Caffeine therapy for apnea of prematurity. N Engl J Med 354: 2112-2121, 2006.
17. Pillekamp F, Hermann C, Keller T, von Gontard A, Kribs A and Roth B: Factors influencing apnea and bradycardia of prematurity-implications for neurodevelopment. Neonatology 91: 155-161, 2007.
18. Ducrocq S, Biran-Mucignat V, Boelle PY, Lebas F, Baudon JJ and Gold F: Apnea of prematurity: Risk factors and ambulatory treatment with caffeine citrate. Arch Pediatr 13: 1299-1304, 2006 (In French).
19. Martin RJ, Abu-Shaweesh JM and Baird TM: Apnoea of prematurity. Paediatr Respir Rev 5 (Suppl A): S377-S382, 2004.
20. Janvier A, Khairy M, Kokkotis A, Cormier C, Messmer D and Barrington KJ: Apnea is associated with neurodevelopmental impairment in very low birth weight infants. J Perinatol 24: 763-768, 2004.
21. Zhao J, Gonzalez F and Mu D: Apnea of prematurity: From cause to treatment. Eur J Pediatr 170: 1097-1105, 2011.
22. Henderson‐Smart, D. J., & De Paoli, A. G. (2010). Methylxanthine treatment for apnoea in preterm infants. Cochrane Database of Systematic Reviews, (12).
23. Pantalitschka, T., Sievers, J., Urschitz, M. S., Herberts, T., Reher, C., & Poets, C. F. (2009). Randomised crossover trial of four nasal respiratory support systems for apnoea of prematurity in very low birthweight infants. Archives of Disease in Childhood-Fetal and Neonatal Edition, 94(4), F245-F248.
24. Lemyre, B., Davis, P. G., & De Paoli, A. G. (2002). Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for apnea of prematurity. Cochrane Database of Systematic Reviews, (1).
25. Koch, G., Datta, A. N., Jost, K., Schulzke, S. M., van den Anker, J., & Pfister, M. (2017). Caffeine citrate dosing adjustments to assure stable caffeine concentrations in preterm neonates. The Journal of pediatrics, 191, 50-5
Downloads
Published
Issue
Section
License
Copyright (c) 2022 https://creativecommons.org/licenses/by/4.0/
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
